The Prognostic Factors of Aluminum Phosphide Poisoning in Urmia: A-five-years Cross-sectional Study Prognostic factors of aluminum phosphide poisoning
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 11 No. 2 (2021),
15 June 2021
,
Page 32663
https://doi.org/10.32598/ijmtfm.v11i2.32663
Abstract
Background: Aluminum phosphide is a highly toxic fungicide. It causes such severe adverse effects as cardiac arrhythmias, metabolic acidosis, acute renal failure, shock, and even death. Therefore, this study investigated the prognostic factors of aluminum phosphide poisoning.
Methods: In this cross-sectional study, all hospitalized patients due to aluminum phosphide poisoning admitted to the poisoning center at Taleghani Hospital, Urmia City, Iran, from 2015 to 2019 were evaluated. The demographics characteristics, clinical findings, and laboratory profiles were retrospectively studied by an investigator-made checklist and evaluated concerning the explored patients’ treatment outcomes. Then, the obtained data were analyzed by descriptive and analytical statistics using SPSS V. 16.
Results: The present study investigated 134 patients (96 males & 38 females). The mortality rate was equal to 29.8% (22.4% males & 7.4% females) in the study patients. The research patients’ Mean±SD age was 28.6±11.5) years. The Mean±SD ingestion amount of aluminum phosphide was 1.48±1.06 g (min=0.2 g, max=15 g). Nausea and vomiting with 119 (88.8%), hypotension: 89 (66.4%), vertigo: 80 (59.7%), and sinus tachycardia: 74 (55.2%) were the most signs and symptoms in the study patients, respectively. Statistically significant relationships (P<0.05) were found between the patients’ treatment outcomes and white blood cells, direct bilirubin, Hco3, base excess, magnesium, Aspartate Aminotransferase, Alanine Aminotransferase, Blood Urea Nitrogen, creatinine, blood glucose, pH, prothrombin time, and the international normalized ratio. Furthermore, significant relationships were detected between the patients’ treatment outcomes and leukocytosis, hypokalemia, hyperglycemia, and hypoglycemia (P<0.05).
Conclusion: Such prognostic factors as demographics characteristics, clinical findings, laboratory profiles, and electrolytes could be used as good indices of the severity of toxicity in patients; accordingly, such data are beneficial for the proper management of patients by healthcare providers. Therefore, prognostic factors should be considered in the diagnosis, treatment, and follow-up stages for these patients.
- Aluminum phosphide, Poisoning, Prognosis, Mortality
How to Cite
References
[2]. Hassanian Moghaddam H, Zamani N. Therapeutic role of hyperinsulinemia/euglycemia in aluminum phosphide poisoning. Medicine (Baltimore). 2016;95(31): e4349. [Doi: 10.1097/MD.0000000000004349] [PMID][PMCID]
[3]. Navabi SM, Navabi J, Aghaei A, Shaahmadi Z, Heydari R. Mortality from aluminum phosphide poisoning in Kermanshah Province, Iran: characteristics and predictive factors. Epidemiol Health. 2018;40: e2018022. [Doi: 10.4178/epih. e2018022] [PMID][PMCID]
[4]. Erfantalab P, Soltaninejad K, Shadnia S, Zamani N, Hassanian-Moghaddam H, Mahdavinejad A, et al. Trend of blood lactate level in acute aluminum phosphide poisoning. World J Emerg Med. 2017;8(2):116-120. [Doi: 10.5847/wjem.j.1920-8642.2017.02.006] [PMID] [PMCID]
[5]. Shadnia S, Sasanian G, Allami P, Hosseini A, Ranjbar A, Amini Shirazi N, et al. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: opportunities for prevention. Hum Exp Toxicol 2009; 28(4), 209–213. [Doi: 10.5847/wjem.j.1920-8642.2017.02.006] [PMID]
[6]. Etemadi Aleagha A, Akhgari M, Iravani FS. Aluminum Phosphide Poisoning-Related Deaths in Tehran, Iran, 2006 to 2013. Medicine (Baltimore). 2015;94(38): e1637. [Doi: 10.1097/MD.0000000000001637] [PMID] [PMCID]
[7]. Farzaneh E, Ghobadi H, Akbarifard M, Nakhaee S, Amirabadizadeh A, Akhavanakbari G, et al. Prognostic Factors in Acute Aluminium Phosphide Poisoning: A Risk-Prediction Nomogram Approach. Basic Clin Pharmacol Toxicol. 2018;123(3):347-355. [Doi: 10.1111/bcpt.13005] [PMID]
[8]. Olson KR, Anderson IB, Benowitz NL, Blanc PD, Clark RF, Kearney TE, et al. Poisoning and drug overdose. 7th ed. New York: McGraw-Hill Education; 2017, p. 306-307.
[9]. Beyranvand MR, Farrokhi S, Peyvandi H, Soltaninejad K, Shadnia S. The effects of amiodarone prophylaxis on cardiac dysrhythmia in acute aluminium phosphide poisoning. Arh Hig Rada Toksikol. 2019;70(1):49-53. [Doi: 10.2478/aiht-2019-70-3162] [PMID]
[10]. Taghaddosinejad F, Farzaneh E, Ghazanfari Nasrabad M, Eizadi Mood N, Hajihosseini M, Mehrpour O. The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case-control study. Springerplus. 2016;5(1):1948. [Doi: 10.1186/s40064-016-3630-2] [PMID] [PMCID]
[11]. Mashayekhian M, Hassanian Moghaddam H, Rahimi M, Zamani N, Aghabiklooei A, Shadnia S. Elevated Carboxyhaemoglobin Concentrations by Pulse CO-Oximetry is Associated with Severe Aluminium Phosphide Poisoning. Basic Clin Pharmacol Toxicol. 2016;119(3):322-329. [Doi: 10.1111/bcpt.12571] [PMID]
[12]. Maleki A, Hosseini MJ, Rahimi N, Abdollahi A, Akbarfakhrabadi A, Javadian N, et al. Adjuvant potential of selegiline in treating acute toxicity of aluminium phosphide in rats. Basic Clin Pharmacol Toxicol. 2019;125(1):62-74. [Doi: 10.1111/bcpt.13207] [PMID]
[13]. Tehrani H, Halvaie Z, Shadnia S, Soltaninejad K, Abdollahi M. Protective effects of N-acetylcysteine on aluminum phosphide-induced oxidative stress in acute human poisoning. Clin Toxicol (Phila). 2013;51(1):23-28. [Doi: 10.3109/15563650.2012.743029] [PMID]
[14]. Karimani A, Mohammadpour AH, Zirak MR, Rezaee R, Megarbane B, Tsatsakis A, et al. Antidotes for aluminum phosphide poisoning - An update. Toxicol Rep. 2018; 5:1053-1059. [Doi: 10.1016/j.toxrep.2018.10.009] [PMID] [PMCID]
[15]. Sharma A, Balasubramanian P, Gill KD, Bhalla A. Prognostic Significance of Blood Glucose Levels and Alterations Among Patients with Aluminium Phosphide Poisoning. Sultan Qaboos Univ Med J. 2018;18(3): e299-e303. [Doi: 10.18295/squmj.2018.18.03.006] [PMID] [PMCID]
[16]. Mostafazadeh B, Pajoumand A, Farzaneh E, Aghabiklooei A, Rasouli MR. Blood levels of methemoglobin in patients with aluminum phosphide poisoning and its correlation with patient's outcome. J Med Toxicol. 2011;7(1):40-43. [Doi: 10.1007/s13181-010-0121-7] [PMID] [PMCID]
[17]. Louriz M, Dendane T, Abidi K, Madani N, Abouqal R, Zeggwagh AA. Prognostic factors of acute aluminum phosphide poisoning. Indian J Med Sci. 2009 ;63(6):227-34. [Doi: 10.4103/0019-5359.53386] [PMID]
[18]. Kordrostami R, Akhgari M, Ameri M, Ghadipasha M, Aghakhani K. Forensic toxicology analysis of self-poisoning suicidal deaths in Tehran, Iran; trends between 2011-2015. Daru. 2017;25(1):15. [Doi: 10.1186/s40199-017-0181-1] [PMID] [PMCID]
[19]. Hosseinian A, Pakravan N, Rafiei A, Feyzbakhsh SM. Aluminum phosphide poisoning known as rice tablet: A common toxicity in North Iran. Indian J Med Sci. 2011;65(4):143-150. [Doi: 10.4103/0019-5359.104777] [PMID]
[20]. Moghadamnia AA. An update on toxicology of aluminum phosphide. Daru. 2012;20(1):25. [Doi: 10.1186/2008-2231-20-25] [PMID] [PMCID]
- Abstract Viewed: 525 times
- pdf Downloaded: 516 times